Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Chowdhury, Sanjib ^a   Howell, Gillian M ^a   Rajput, Ashwani ^b   Teggart, Carol A ^a   Brattain, Lisa E ^a   Weber, Hannah R ^a   Chowdhury, Aparajita ^a   Brattain, Michael G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; SURVIVIN; TRANSFORMING GROWTH FACTOR BETA; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; NUDE MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL SURVIVAL; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955783609     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019335     Document Type: Article

References (49)

1. Stein U, Walther W, Arlt F, Schwabe H, Smith J, et al. (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15: 59-67.
2. Markowitz SD, Itzkowitz SH, Berger BM, (2009) The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med 150: 816-817; author reply 819-820.
3. Mehlen P, Puisieux A, (2006) Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458.
4. Liu P, Cheng H, Roberts TM, Zhao JJ, (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
5. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, et al. (2010) IAP regulation of metastasis. Cancer Cell 17: 53-64.
6. Jakowlew SB, (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25: 435-457.
7. Sun L, Wu G, Willson JK, Zborowska E, Yang J, et al. (1994) Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455.
8. Wang J, Han W, Zborowska E, Liang J, Wang X, et al. (1996) Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271: 17366-17371.
9. Wang J, Sun L, Myeroff L, Wang X, Gentry LE, et al. (1995) Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049.
10. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
11. Borczuk AC, Kim HK, Yegen HA, Friedman RA, Powell CA, (2005) Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. Am J Respir Crit Care Med 172: 729-737.
12. Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, et al. (2000) Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology 36: 168-177.
13. Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, et al. (2008) Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Res 68: 3152-3160.
14. Dohi T, Okada K, Xia F, Wilford CE, Samuel T, et al. (2004) An IAP-IAP complex inhibits apoptosis. J Biol Chem 279: 34087-34090.
15. Zhang L, Duan CJ, Binkley C, Li G, Uhler MD, et al. (2004) A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A. Mol Cell Biol 24: 2169-2180.
16. Taylor SS, Yang J, Wu J, Haste NM, Radzio-Andzelm E, et al. (2004) PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta 1697: 259-269.
17. Dohi T, Xia F, Altieri DC, (2007) Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 27: 17-28.
18. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S, (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424.
19. Pereira ME, Wilk S, (1990) Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase. Arch Biochem Biophys 283: 68-74.
20. Zhang F, Paterson AJ, Huang P, Wang K, Kudlow JE, (2007) Metabolic control of proteasome function. Physiology (Bethesda) 22: 373-379.
21. Zhang F, Hu Y, Huang P, Toleman CA, Paterson AJ, et al. (2007) Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 282: 22460-22471.
22. Welch EJ, Jones BW, Scott JD, (2010) Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 10: 86-97.
23. Newell AE, Fiedler SE, Ruan JM, Pan J, Wang PJ, et al. (2008) Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction. Cell Motil Cytoskeleton 65: 539-552.
24. Jarnaess E, Ruppelt A, Stokka AJ, Lygren B, Scott JD, et al. (2008) Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type I. J Biol Chem 283: 33708-33718.
25. Rogne M, Stokka AJ, Tasken K, Collas P, Kuntziger T, (2009) Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network. Hum Mol Genet 18: 978-987.
26. Carlucci A, Lignitto L, Feliciello A, (2008) Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome. Trends Cell Biol 18: 604-613.
27. Schillace RV, Voltz JW, Sim AT, Shenolikar S, Scott JD, (2001) Multiple interactions within the AKAP220 signaling complex contribute to protein phosphatase 1 regulation. J Biol Chem 276: 12128-12134.
28. Hong K, Lou L, Gupta S, Ribeiro-Neto F, Altschuler DL, (2008) A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation. J Biol Chem 283: 23129-23138.
29. Eichhorn PJ, Creyghton MP, Bernards R, (2009) Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 1795: 1-15.
30. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, et al. (2004) Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279: 5405-5412.
31. Guo XN, Rajput A, Rose R, Hauser J, Beko A, et al. (2007) Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model. Cancer Res 67: 5851-5858.
32. Ongchin M, Sharratt E, Dominguez I, Simms N, Wang J, et al. (2009) The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer. J Surg Res 156: 250-256.
33. Wang J, Rajput A, Kan JL, Rose R, Liu XQ, et al. (2009) Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma. J Biol Chem 284: 10912-10922.
34. Ye SC, Foster JM, Li W, Liang J, Zborowska E, et al. (1999) Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Cancer Res 59: 4725-4731.
35. Eckelman BP, Salvesen GS, Scott FL, (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7: 988-994.
36. Janssens V, Goris J, (2001) Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353: 417-439.
37. Petritsch C, Beug H, Balmain A, Oft M, (2000) TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 14: 3093-3101.
38. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, et al. (1988) Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci U S A 85: 1768-1771.
39. Ammanamanchi S, Brattain MG, (2001) 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3. J Biol Chem 276: 32854-32859.
40. Ammanamanchi S, Brattain MG, (2004) Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J Biol Chem 279: 32620-32625.
41. Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG, (2000) Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene 19: 4660-4667.
42. Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW, (2001) Reversion of transcriptional repression of Sp1 by 5 aza-2′ deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2. Cancer Res 61: 6239-6247.
43. Ammanamanchi S, Brattain MG, (2001) Sp3 is a transcriptional repressor of transforming growth factor-beta receptors. J Biol Chem 276: 3348-3352.
44. Liu Y, Zhong X, Li W, Brattain MG, Banerji SS, (2000) The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. J Biol Chem 275: 12231-12236.
45. Buck MB, Fritz P, Dippon J, Zugmaier G, Knabbe C, (2004) Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. Clin Cancer Res 10: 491-498.
46. Boyd DD, Levine AE, Brattain DE, McKnight MK, Brattain MG, (1988) Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. Cancer Res 48: 2469-2474.
47. Heider U, von Metzler I, Kaiser M, Rosche M, Sterz J, et al. (2008) Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. Eur J Haematol 80: 133-142.
48. Hu YP, Patil SB, Panasiewicz M, Li W, Hauser J, et al. (2008) Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Res 68: 8004-8013.
49. Rajput A, Koterba AP, Kreisberg JI, Foster JM, Willson JK, et al. (2007) A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo. Cancer Res 67: 665-673.